Autolus Therapeutics Ltd (AUTL) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-0.16x
Autolus Therapeutics Ltd (AUTL) has a Cash Flow-to-Debt Ratio of -0.16x as of March 2026, meaning its operating cash flow of $-65.32 Million could theoretically repay 0% of its total liabilities ($418.24 Million) in one year. See AUTL financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.16x
Operating CF / Total Liabilities
Operating Cash Flow
$-65.32 Million
USD
Total Liabilities
$418.24 Million
USD
Data as of
Mar 2026
Most recent filing
Autolus Therapeutics Ltd Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Autolus Therapeutics Ltd across 12 annual periods. For the full cash flow conversion analysis, see Autolus Therapeutics Ltd (AUTL) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Autolus Therapeutics Ltd (2015–2025)
Year-by-year debt coverage analysis for Autolus Therapeutics Ltd.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.69x | $-283.57 Million | $410.94 Million | ▼ -18.9% |
| 2024 | -0.58x | $-206.27 Million | $355.40 Million | ▼ -5.2% |
| 2023 | -0.55x | $-145.59 Million | $263.91 Million | ▲ +5.9% |
| 2022 | -0.59x | $-112.31 Million | $191.60 Million | ▲ +54.1% |
| 2021 | -1.28x | $-117.86 Million | $92.24 Million | ▲ +8.6% |
| 2020 | -1.40x | $-117.76 Million | $84.20 Million | ▲ +32.9% |
| 2019 | -2.08x | $-101.48 Million | $48.69 Million | ▼ -0.9% |
| 2018 | -2.06x | $-25.85 Million | $12.52 Million | ▲ +0.0% |
| 2018 | -2.06x | $-25.85 Million | $12.52 Million | ▲ +23.5% |
| 2017 | -2.70x | $-16.36 Million | $6.06 Million | ▲ +4.3% |
| 2016 | -2.82x | $-9.85 Million | $3.49 Million | ▼ -65.2% |
| 2015 | -1.71x | $-3.33 Million | $1.95 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.